Wockhardt gets US FDA nod for epilepsy drug
Reuters - Thursday, February 12
MUMBAI, Feb 11 - Drug maker Wockhardt Ltd <WCKH.BO> on Wednesday said
it has received approval from the U.S. Food & Drug Administration to
market epilepsy drug, Divalproex Sodium extended release tablets.
The firm has got final approval for 250 mg doses of the drug and
tentative approval for 500 mg doses, it added.
The 250 mg tablets will be launched in the US shortly, while the 500
mg tablets will be launched in early August, the firm added.
* Email Story
* IM Story
* Printable View
* Blog This
__._,_.___
Just a friendly reminder: Please remember to sign your post and remember to clean up messages when you reply to them. This is especially important if you are on digest. This not only helps out the list owner but, it makes messages much easier to read when they arrive in our inboxes.
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
.
__,_._,___
No comments:
Post a Comment